Video Experimental Relacionado

Updated: Jul 6, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

La atorvastatina inhibe la calcificación inducida por la hipercolesterolemia en las válvulas aórticas a través de la

Nalini M Rajamannan¹, Malayannan Subramaniam, Frank Caira

¹Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. n-rajamannan@northwestern.edu

|September 15, 2005

Resumen

La atorvastatina reduce la calcificación de la válvula aórtica en la hipercolesterolemia al inhibir la vía Lrp5/beta-catenina. Esta vía es crucial para la proliferación celular y la formación de hueso en la enfermedad valvular del corazón.

Área de la Ciencia:

Biología Cardiovascular Biología Cardiovascular
La medicina molecular es una medicina molecular.
La biomineralización es la biomineralización.

Sus antecedentes:

La enfermedad de la válvula aórtica calcifica es una de las principales causas de reemplazo de válvula.
Los mecanismos celulares que impulsan la calcificación de las válvulas siguen sin estar claros.
La proteína 5 relacionada con el receptor de baja densidad (Lrp5) es vital para la proliferación celular y la osteoblastogénesis a través de la señalización de la beta-catenina.

Objetivo del estudio:

Para investigar el papel de Lrp5 en la calcificación de la válvula aórtica (AV) durante la hipercolesterolemia experimental.
Para determinar el efecto de la atorvastatina en la calcificación AV y las vías moleculares asociadas.

Principales métodos:

Los conejos de Watanabe fueron alimentados con dietas normales, enriquecidas con colesterol o enriquecidas con colesterol con atorvastatina.
Se analizaron las válvulas aórticas para la proliferación celular, la señalización de Lrp5 / beta-catenina y los marcadores de la matriz ósea.
En estudios in vitro se examinó el efecto de la atorvastatina en la proliferación de los miofibroblastos AV y en la vía Lrp5/beta-catenina.

Principales resultados:

La dieta con colesterol indujo la calcificación AV con aumento de la expresión de Lrp5, osteopontina y p42/44.
El tratamiento con atorvastatina redujo significativamente la formación ósea AV, la proliferación celular y los niveles de Lrp5/beta-catenina.
Los hallazgos in vitro confirmaron la participación de Lrp5/beta-catenina en la proliferación de los miofibroblastos.

Conclusiones:

La calcificación AV hipercolesterolemia es atenuada por la atorvastatina.
La vía Lrp5/beta-catenina es un mediador clave en este proceso.
Dirigirse a esta vía puede ofrecer estrategias terapéuticas para la enfermedad valvular cardíaca.

Más Videos Relacionados

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Published on: November 20, 2017

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Videos de Conceptos Relacionados

Antihypertensive Drugs: Action of Calcium Channel Blockers

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...